ADMS
Adamas Pharmaceuticals, Inc.
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
84 hedge funds and large institutions have $207M invested in Adamas Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 15 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
-9
Holders Change %
-9.68%
% of All Funds
2.24%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
19
Increased
38
Reduced
15
Closed
26
Calls
$37K
Puts
–
Net Calls
+$37K
Net Calls Change
-$690K
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
AQR Capital Management
Greenwich,
Connecticut
| – | -$282K | -9,964 | Closed |
|
102
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$236K | -8,322 | Closed |
|
|
GCP
103
GSA Capital Partners
London,
United Kingdom
| – | -$215K | -7,600 | Closed |
|
104
Two Sigma Advisers
New York
| – | -$201K | -7,100 | Closed |
|
105
Bank of America
Charlotte,
North Carolina
| – | -$94K | -3,319 | Closed |
|
106
Group One Trading
Chicago,
Illinois
| – | -$66K | -2,330 | Closed |
|
107
BNP Paribas Financial Markets
Paris,
France
| – | -$57.9K | -2,046 | Closed |
|
108
UBS Group
Zurich,
Switzerland
| – | -$54K | -1,891 | Closed |
|